Replication Is Dead. Corroboration Is the Standard Clinical Trials Must Meet Now.

The biomedical field is shifting its clinical trial validation standard from replication—repeating identical studies—to corroboration—converging independent evidence from diverse methods. This new approach demands methodological pluralism to build more reliable evidence packages and address the high cost and patient risk linked to reliance on repeated but non-corrobative trials.

This Wire brief sits within Fusion42's coverage of Biotech.